![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Well DMX bit the dust and now NRI is carrying on with research. Sigh. DMX had a great product: Pennsaid. Too bad they could not do anything with it. This drug was the only reason I was interested in DMX and I am glad to hear that NRI is progressing the day when Pennsaid will be available worldwide: new.stockwatch.com Haven't we been here before?<ng> Anyway I thought the header should be updated to reflect the current situation. | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |